Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Vaccines
|
September 28, 2023
Oncolytic Viruses: An Inventory of Shedding Data from Clinical Trials and Elements for the Environmental Risk Assessment
Sheela Onnockx, Aline Baldo, Katia Pauwels
Current Gene Therapy
|
January 9, 2014
Biosafety of gene therapy vectors derived from herpes simplex virus type 1
Filip Lim, Hena Khalique, Maria Ventosa, et al.
Vaccines
|
June 2, 2021
Environmental Risk Assessment of Recombinant Viral Vector Vaccines against SARS-Cov-2
Aline Baldo, Amaya Leunda, Nicolas Willemarck, et al.
Human Vaccines & Immunotherapeutics
|
December 4, 2015
Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination
Aline Baldo, Evanthia Galanis, Frédéric Tangy, et al.
FEMS Immunology and Medical Microbiology
|
December 4, 2008
Secreted dipeptidyl peptidases as potential virulence factors for Microsporum canis
Sandy Vermout, Aline Baldo, Jérémy Tabart, et al.
Veterinary Dermatology
|
May 15, 2008
Reconstructed interfollicular feline epidermis as a model for the screening of antifungal drugs against Microsporum canis
Jeremy Tabart, Aline Baldo, Sandy Vermout, et al.
Prion
|
September 24, 2013
Laboratory activities involving transmissible spongiform encephalopathy causing agents: risk assessment and biosafety recommendations in Belgium
Amaya Leunda, Bernadette Van Vaerenbergh, Aline Baldo, et al.
Mycopathologia
|
May 15, 2008
Pathogenesis of dermatophytosis
Sandy Vermout, Jérémy Tabart, Aline Baldo, et al.
Current Opinion in Infectious Diseases
|
March 5, 2008
Immunization and dermatophytes
Bernard Mignon, Jérémy Tabart, Aline Baldo, et al.
FEMS Microbiology Letters
|
August 8, 2007
RNA silencing in the dermatophyte Microsporum canis
Sandy Vermout, Jérémy Tabart, Aline Baldo, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Vaccines
|
September 28, 2023
Oncolytic Viruses: An Inventory of Shedding Data from Clinical Trials and Elements for the Environmental Risk Assessment
Sheela Onnockx, Aline Baldo, Katia Pauwels
Current Gene Therapy
|
January 9, 2014
Biosafety of gene therapy vectors derived from herpes simplex virus type 1
Filip Lim, Hena Khalique, Maria Ventosa, et al.
Vaccines
|
June 2, 2021
Environmental Risk Assessment of Recombinant Viral Vector Vaccines against SARS-Cov-2
Aline Baldo, Amaya Leunda, Nicolas Willemarck, et al.
Human Vaccines & Immunotherapeutics
|
December 4, 2015
Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination
Aline Baldo, Evanthia Galanis, Frédéric Tangy, et al.
FEMS Immunology and Medical Microbiology
|
December 4, 2008
Secreted dipeptidyl peptidases as potential virulence factors for Microsporum canis
Sandy Vermout, Aline Baldo, Jérémy Tabart, et al.
Veterinary Dermatology
|
May 15, 2008
Reconstructed interfollicular feline epidermis as a model for the screening of antifungal drugs against Microsporum canis
Jeremy Tabart, Aline Baldo, Sandy Vermout, et al.
Prion
|
September 24, 2013
Laboratory activities involving transmissible spongiform encephalopathy causing agents: risk assessment and biosafety recommendations in Belgium
Amaya Leunda, Bernadette Van Vaerenbergh, Aline Baldo, et al.
Mycopathologia
|
May 15, 2008
Pathogenesis of dermatophytosis
Sandy Vermout, Jérémy Tabart, Aline Baldo, et al.
Current Opinion in Infectious Diseases
|
March 5, 2008
Immunization and dermatophytes
Bernard Mignon, Jérémy Tabart, Aline Baldo, et al.
FEMS Microbiology Letters
|
August 8, 2007
RNA silencing in the dermatophyte Microsporum canis
Sandy Vermout, Jérémy Tabart, Aline Baldo, et al.
Page
of 2